ArriVent BioPharma, Inc. Common Stock
$28.36
Market Cap
$1.40B
Shares Outstanding
49.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 26, 2024
Round Lot
100
Locale
US
Day Open
$28.24
Day High
$28.45
Day Low
$27.84
Volume
456.4K
VWAP
$28.24
Prev Close
$27.65
Transactions
--
Acc. Volume
--
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
ArriVent BioPharma, Inc. Common Stock (AVBP) closed the 2026-09-17 session at $28.36, up 2.57% versus the previous close (+0.71). The stock opened at $28.24 and traded between $27.84 and $28.45 during that session. Session trading volume was 456K shares. The volume-weighted average price (VWAP) is $28.24.
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
ArriVent BioPharma, Inc. Common Stock has a market capitalization of $1.40 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. AVBP is listed on the XNAS exchange. The company employs approximately 77 people. ArriVent BioPharma, Inc. Common Stock is headquartered in NEWTOWN SQUARE, PA. The recorded listing date is 2024-01-26.
On this page you can find market AVBP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.